<DOC>
	<DOC>NCT00651612</DOC>
	<brief_summary>This study evaluates the safety of brimonidine/timolol fixed combination in glaucoma or ocular hypertension patients</brief_summary>
	<brief_title>Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis of ocular hypertension or glaucoma Patient requires IOPlowering therapy in both eyes Uncontrolled medical conditions Contraindication to Î²adrenoceptor antagonist therapy or brimonidine therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>